Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		102,619,383
Beginning balance at Dec. 31, 2022	$ 60,180	$ 1	$ 1,742,114	$ (19,522)	$ (1,662,413)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		21,049
Issuance of common stock upon exercise of stock options	157		157
Vesting of restricted stock units (in shares)		67,873
Taxes paid related to net share settlement of restricted stock units	(993)		(993)
Stock-based compensation	22,266		22,266
Other comprehensive income (loss)	7,372			7,372
Net loss	(133,533)				(133,533)
Ending balance (in shares) at Mar. 31, 2023		102,708,305
Ending balance at Mar. 31, 2023	(44,551)	$ 1	1,763,544	(12,150)	(1,795,946)
Beginning balance (in shares) at Dec. 31, 2023		121,629,861
Beginning balance at Dec. 31, 2023	$ 158,684	$ 1	2,304,220	(3,675)	(2,141,862)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	36,791	36,791
Issuance of common stock upon exercise of stock options	$ 213		213
Vesting of restricted stock units (in shares)		120,645
Taxes paid related to net share settlement of restricted stock units	(1,544)		(1,544)
Stock-based compensation	27,041		27,041
Other comprehensive income (loss)	(1,124)			(1,124)
Net loss	(114,985)				(114,985)
Ending balance (in shares) at Mar. 31, 2024		121,787,297
Ending balance at Mar. 31, 2024	$ 68,285	$ 1	$ 2,329,930	$ (4,799)	$ (2,256,847)